Pancreatic cancer RNA vaccine shows durable T cell immunity

by

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional CD8+ T cells in patients with pancreatic ductal adenocarcinoma (PDAC), potentially delaying disease recurrence.

Leave A Comment

Your email address will not be published. Required fields are marked *